Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma
• Treatments: Etiracetam; Levetiracetam; Pharmaceutical Solutions; Piracetam

Criteria

Inclusion Criteria:

• Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study

Exclusion Criteria:

• Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study